Home › Funds › ArrowMark Colorado Holdings LLC › TNGX

ArrowMark Colorado Holdings LLC position in TNGX

TANGO THERAPEUTICS INC · Health Care

ArrowMark Colorado Holdings LLC reported holding 840,492 shares of TNGX (TANGO THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$21.0M, representing 1.00% of its reported portfolio and ranking #12 among its reported holdings. ArrowMark Colorado Holdings LLC has disclosed TNGX holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

Latest position (Q3 2026)840.49K sh
Reported value held$20.97M
Portfolio Weight1.00%
First reportedQ4 2023
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How ArrowMark Colorado Holdings LLC's TNGX position evolved

ArrowMark Colorado Holdings LLC first disclosed a stake in TNGX in Q4 2023 at 708,385 shares (US$7.0M). The position peaked in Q2 2026 at 708,385 shares, worth US$22.1M. Across 12 filings, ArrowMark Colorado Holdings LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 10 time(s). The most recent filing (Q3 2026) shows 840,492 shares valued at US$21.0M — an increase of 132,107 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2023 708.38K $7.01M New
Q1 2024 708.38K $5.62M Hold
Q2 2024 708.38K $6.08M Hold
Q3 2024 708.38K $5.45M Hold
Q4 2024 708.38K $2.19M Hold
Q1 2025 708.38K $970.49K Hold
Q2 2025 708.38K $3.63M Hold
Q3 2025 708.38K $5.95M Hold
Q4 2025 708.38K $6.28M Hold
Q1 2026 708.38K $14.82M Hold
Q2 2026 708.38K $22.14M Hold
Q3 2026 840.49K $20.97M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TNGX and 13F data

TNGX (TANGO THERAPEUTICS INC) is a Health Care company. 69 other funds we track also report a position in TNGX — the largest reported positions include Farallon Capital Management (US$383.8M), RTW INVESTMENTS, LP (US$350.5M), Boxer Capital Management, LLC (US$340.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TNGX

All TNGX fund holders →

FAQ

How long has ArrowMark Colorado Holdings LLC held TNGX?

ArrowMark Colorado Holdings LLC has disclosed TNGX holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

What is ArrowMark Colorado Holdings LLC's current position in TNGX?

As of Q3 2026, ArrowMark Colorado Holdings LLC holds 840.49K shares of TNGX (TANGO THERAPEUTICS INC), valued at $20.97M, representing 1.00% of its reported portfolio and ranking #12.

Has ArrowMark Colorado Holdings LLC been buying or selling TNGX?

In the latest 13F filing (Q3 2026), ArrowMark Colorado Holdings LLC increased its position in TNGX. The position peaked in Q2 2026 at 708.38K shares.

Which other funds hold TNGX?

Other major institutional holders of TNGX include Farallon Capital Management, RTW INVESTMENTS, LP, Boxer Capital Management, LLC, among 69 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.